CNO officer plans $329K stock sale, 5,964 shares

CNO Financial Group officer Karen DeToro filed a Rule 144 notice to sell 5,964 CNO common shares, following two recent sales of similar size.

Rhea-AI Filing Summary

CNO Financial Group, Inc. (CNO) has a filing indicating that officer Karen DeToro plans to sell 5,964 shares of common stock under Rule 144 through Morgan Stanley Smith Barney LLC, with an aggregate market value of $328,728.52 as of the notice date.

The notice also lists prior sales by DeToro in the last three months totaling 9,336 shares on September 1, 2026 for $511,002.96 and 9,374 shares on August 31, 2026 for $515,366.21. The shares to be sold were acquired upon vesting of restricted stock and Performance Shares between January 2, 2025 and February 11, 2025.

Key Figures

Planned shares to be sold: 5,964 shares Aggregate market value of planned sale: $328,728.52 Shares sold on September 1, 2026: 9,336 shares +3 more

6 metrics

Planned shares to be sold 5,964 shares CNO common stock to be sold under Rule 144 by officer Karen DeToro

Aggregate market value of planned sale $328,728.52 Market value for 5,964 CNO shares covered by the Rule 144 notice

Shares sold on September 1, 2026 9,336 shares CNO common stock sold by Karen DeToro in the past three months

Proceeds on September 1, 2026 sale $511,002.96 Value of 9,336 CNO common shares sold by Karen DeToro

Shares sold on August 31, 2026 9,374 shares CNO common stock sold by Karen DeToro in the past three months

Proceeds on August 31, 2026 sale $515,366.21 Value of 9,374 CNO common shares sold by Karen DeToro

Key Terms

Rule 144, restricted stock, Performance Shares

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

restricted stock financial

"The securities to be sold were acquired upon the vesting of restricted stock"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Performance Shares financial

"acquired upon the vesting of restricted stock and Performance Shares"

Performance shares are a type of company stock given to executives or employees that only become theirs if the company meets specific goals, like hitting certain profits or growth targets. They motivate leaders to work toward the company’s success, because their additional shares depend on achieving these results.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filed for CNO indicate about planned share sales?

The Form 144 indicates that officer Karen DeToro intends to sell 5,964 shares of CNO common stock under Rule 144, through Morgan Stanley Smith Barney LLC, with an aggregate market value of about $328,728.52 as of the notice date.

How many CNO (CNO) shares has Karen DeToro sold recently?

The filing reports that Karen DeToro sold 9,336 shares of CNO common stock on September 1, 2026 for $511,002.96 and 9,374 shares on August 31, 2026 for $515,366.21 during the past three months.

What is the origin of the CNO shares covered by this Form 144?

The filing states the securities to be sold were acquired upon the vesting of restricted stock and Performance Shares during the period from January 2, 2025 through February 11, 2025.

What is the reported market value of the CNO shares Karen DeToro plans to sell?

The Form 144 reports an aggregate market value of approximately $328,728.52 for the 5,964 shares of CNO common stock that Karen DeToro plans to sell under Rule 144.

Through which broker will the planned CNO (CNO) Rule 144 sale be executed?

The filing lists Morgan Stanley Smith Barney LLC Executive Financial Services at New York Plaza as the broker for the planned sale of 5,964 CNO common shares under Rule 144.

When was the Rule 144 notice for CNO shares dated and signed?

The notice is dated September 2, 2026 and is signed /s/ Karen J DeToro, in connection with the planned sale of 5,964 CNO common shares under Rule 144.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/02/2026 - 04:12 PM EDT Accepted by SEC EDGAR 09/02/2026 - 04:12 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001789577
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CNO FINANCIAL GROUP, INC.
SEC File Number	001-31792
Address of Issuer	11299 Illinois Street Carmel INDIANA 46032
Phone	(317) 817-6100
Name of Person for Whose Account the Securities are To Be Sold	KAREN DETORO
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	5964	328728.52	92521371	09/02/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/02/2025	Performance and Restricted Stock	ISSUER			5964	01/02/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
KAREN DETORO 11299 Illinois Street Carmel IN 46032	Common	09/01/2026	9336	511002.96
KAREN DETORO 11299 Illinois Street Carmel IN 46032	Common	08/31/2026	9374	515366.21

144: Remarks and Signature

Remarks	The securities to be sold were acquired upon the vesting of restricted stock and Performance Shares during the period of 01/02/2025 through 02/11/2025
Date of Notice	09/02/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	05/11/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Karen J DeToro
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)